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ANALYSIS OF BEST CORRECTED VISUAL ACUITY FOLLOWING 
CORNEAL REFRACTIVE SURGERY COMPARING LOW AND STANDARD 
PREDICTED POSTOPERATIVE KERATOMETRY 
RYAN C. DRAKE 
ABSTRACT 
BACKGROUND: It is a commonly held view in the ophthalmologic community that eyes 
with sufficiently low calculated postoperative corneal keratometry, less than 35 diopters, 
should not undergo corrective refractive laser surgery (CRLS) due to the increased risk of 
best corrected visual acuity (BCVA) loss. Typical CRLS include Laser In-Situ 
Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), and Laser-Assisted Sub-
Epithelial Keratectomy (LASEK). Evidence for this claim in currently available literature 
is sparse and inconsistent. 
PURPOSE: To further elucidate the relationship between calculated “flat” postoperative 
corneal keratometry and loss of BCVA. Additionally, to investigate the role of procedure 
type (LASIK, ASA, or LASEK) and degree of calculated postoperative corneal flatness on 
visual outcomes following CRLS. 
METHODS: 222 eyes (111 candidates and 111 controls) were retrospectively analyzed 
and matched based on calculated postoperative keratometry compared to control subgroups 
with calculated postoperative keratometries ≥38 D and further stratified into subgroups 1b  
(K=38-38.99 D), 2b (K=39-39.99 D), 3b (K=40-40.9 9D), and 4b (K≥41 D). All of the 
  vi 
eyes had undergone LASIK, PRK, or LASEK between December 2008 and November 
2016 at Boston Eye Group/Boston Laser in Brookline, MA. 
RESULTS: Statistical analyses showed no significant differences between candidates and 
controls in preoperative BCVA (p=0.650) and postoperative BCVA (p=0.081). Subgroup 
matching showed no significant differences in the amount of tissue ablated in 1a & 1b 
(p=0.946), 2a & 2b (p=0.694), 3a & 3b (p=0.989), and 4a & 4b (p=0.986). There was also 
no significant change between preoperative and postoperative BCVA in subgroups 1a 
(p=0.367), 2a (p=0.297), 3a (p=0.576), 4a (p=0.669), 1b (p=0.458), 2b (p=0.227), 3b 
(p=0.071), or 4b (p=0.703). 3 of 111 (2.70%) candidate eyes and 1 (0.90%) control eye lost 
1+ lines of BCVA following surgery. There was no statistical difference in 1+ lines of 
BCVA lost between these groups (p=0.313). Similarly, the type of CRLS undergone did 
not affect the rate of BCVA line loss (p=0.793). 
CONCLUSION: Our evidence suggests that in a matched comparison of flat and normal 
mathematically predicted postoperative keratometries, there was no increase in BCVA lost 
due to flat keratometry. 
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INTRODUCTION 
 In recent decades refractive surgery has become a safe, proven, and 
effective alternative to spectacles and contact lenses in the treatment of myopia, also known 
as “nearsightedness”. 13 Myopia occurs when light entering the eye is bent too strongly and 
focuses at a point in front of the retina. The retina is a layer at the back of the eye which 
transmits the visual information it reads to the brain. As light converges before it reaches 
the retina, things near to a myope will be clear but things in the distance will be less so. 
Myopia is believed to be caused by a number of factors, ranging from genetics to axial 
length.21  
Refractive Surgery 
Refractive surgery is a group of procedures that correct for refractive error. Surgery 
typically involves the cornea, but may also involve the lens. The cornea lies at the front of 
the eye and is comprised of three main sections: the eyelid facing epithelium, the central 
stroma, and the inner endothelium. Each of these layers serves a distinct functional role. 
The regenerating epithelium protects the stroma from abrasion due to the eyelid and other 
environmental factors. The thick central stroma is comprised largely of connective tissue 
(keratocytes, nerves and dendritic cells), and largely defines the shape of the cornea as a 
whole. The endothelium is a single-layer membrane that separates the stroma from the 
anterior chamber of the eye and is not regenerative.5 Refractive surgery allows for the 
corrections of myopia by changing the shape of the stroma, which in turn changes how 
light is refracted towards the retina. 
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There are 3 common refractive surgical procedures: LASIK (Laser In Situ 
Keratomileusis), LASEK (Laser Epithelial Keratomileusis), and PRK (Photorefractive 
Keratectomy). In an excimer laser-based refractive procedure an appropriate prescription 
is shaped from the patient’s corneal stroma to compensate for their existing refractive error. 
In order to access the stromal layer, the epithelium is either lifted surgically (LASIK and 
LASEK) or removed chemically (PRK). Whether lifted or removed, the area  of epithelium 
altered is typically a 4.5mm radius from the center of the cornea.8 It is important not to 
remove a much wider radius than this, as it is possible to interfere with the stem cells that 
regrow the epithelium located at the corneal limbus. The corneal limbus is the intersection 
of the cornea and the sclera. A typical adult cornea has a diameter of about 11.7mm 
indicating that the limbus resides at a radius of about 5.85mm from the corneal center.16 
The most common refractive surgeries (LASIK, LASEK, and PRK) have near 
equivalent outcomes after stabilization,3,8,22 and differ solely in how they remove the 
epithelium in order to access the stroma. Once the stroma is accessed, an excimer laser is 
used to alter its shape. The exact alteration is determined from the appropriate manifest 
refraction and the laser platform. In traditional refractive surgery the cornea is simply 
treated with the manifest refraction, centered on the pupil. Recent excimer laser platforms 
allow custom-wavefront and wavefront-guided surgery. Wavefront-based systems measure 
light as it travels through the eye in order to reduce aberrations caused by an individual’s 
eye irregular shape. These systems give better visual acuity (VA) and outcomes when 
compared to traditional treatments.12 In LASIK, the cornea is suctioned to give a flat 
surface, and then a “flap” of epithelium is cut  from the cornea at a depth of 100-140µm.9 
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Since the corneal epithelium is typically about 50µm5 this results in a flap that is both 
epithelium and stroma. The flap is cut with either a femtosecond laser or a microkeratome. 
The bladeless laser-based femtosecond technique has gained popularity in recent years, 
largely due to its safety and more consistent flap accuracy.7,14 LASEK also creates a flap, 
but in a different manner than LASIK. In LASEK, the epithelium is loosened with a 
solution (such as 20% ethanol) and the epithelium is lifted as a hinged sheet. There is less 
postoperative pain when compared to PRK, but it takes a similar amount of time for vision 
to stabilize. In PRK there is no flap made. Instead the epithelium is chemically removed, 
usually with an alcohol or similar solvent. It can also be removed mechanically with a blade 
or rotating alger brush.22 A metal trephine is pressed by the surgeon onto the cornea and 
the solvent is placed into the well for a short amount of time, generally less than one minute. 
Then it is washed away with copious amounts of saline and the newly pliable epithelium 
is removed with a small surgical sponge. This leaves a smooth surface ready for excimer 
laser treatment.2 
“Flat” Corneal Keratometry 
In the ophthalmology community it is a commonly-held belief that if excimer laser 
treatment of myopia reduces the curvature of the central cornea beyond a specific range, 
there may be a loss in achievable visual acuity.23 This range has historically been defined 
as a postoperative keratometry value of <35 diopter (D). 
Multiple investigations have examined the relationship between preoperative 
keratometry values and visual acuity following myopic laser vision correction. In 2001 Rao 
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et al.15 studied preoperative keratometry from 103 myopic LASIK patients and compared 
it to their postoperative visual acuity. All patients were considered highly myopic, with 
manifest spherical equivalence (SE) ranging from -6.0 to -13.0 D. Regression analyses 
found that in eyes with similar preoperative manifest, eyes with “flatter” keratometry 
(<43.5 D) were more likely to contain residual prescription post-surgery compared to eyes 
with “steeper” keratometry (>44.5 D). 
A series of 96 moderately myopic eyes, with SE from -2.00 to -5.99 D, were 
compared along similar lines in 2012. Christiansen et al.3 found results contradictory to 
those found in high myopes. In their case flatter corneas (K<42 D) achieved better visual 
acuities than those with steeper corneas (K>46 D). A few explanations proposed include 
positive induced spherical aberrations, corneal asphericity, and tissue remodeling. 
This issue has also been studied in hyperopic eyes. Cobo-Soriano et al.4 studied 376 
eyes with an average preoperative manifest SE of +4.04 D. They defined flat keratometry 
as <43 D and steep keratometry as greater or equal to that. They found that there was no 
dependence of postoperative results on preoperative keratometry. According to their 
results, they proposed that postoperative vision relied only the degree of hyperopia 
corrected and was independent of preoperative keratometry. 
Although many studies15,24 look at the overall change in keratometry and its effect 
on VA following refractive surgery, they do not explore if this change leaves the patients 
with flat keratometry postoperatively. As such, current literature fails to convincingly 
explore the relationship between predicted or measured flat postoperative keratometry and 
visual acuity. Varssano et al.23 attempted to tackle this issue in 2013. An investigation into 
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PRK patients with postoperatively flat corneas (K<35 D) revealed no loss in corrected 
visual acuity (BCVA). However this study did not stratify the degree of corneal flatness 
and the amount of “flatness” affected BCVA. They also excluded patients undergoing 
LASIK or LASEK. 
In 2015 Mostafa11 looked at the degree of keratometric change following laser 
vision correction (LVC) and how it affected VA. Yet this investigation only included 
results from highly myopic patients, with manifest SE from -6 to -12 D. Another 2015 
study19 looked at postoperative keratometry, but only its relation to patient satisfaction and 
night-vision. Thus, the current body of literature would stand to benefit from further 
elucidation of the relationship between myopic corneal flattening following corrective 
refractive laser surgery (CRLS) and loss of BCVA.  
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OBJECTIVES 
Our aim was to further investigate the relationship between degree of myopic 
corneal flattening following CRLS and loss of BCVA. Current belief is that patients at risk 
for significant postoperative corneal flattening should not undergo CRLS. To substantiate 
or refute this claim clinical data was retrospectively analyzed across eyes that had 
undergone LASIK, LASEK, or PRK. 
We considered three main endpoints crucial to the elucidation of this topic. One, 
determine the existence of a relationship between predicted postoperative keratometry 
values of <38 D and loss of BCVA. Two, determine the existence of a relationship between 
VA outcomes and the degree of corneal flatness, as separated by keratometry subgroups: 
Subgroup 1a (K<35 D), Subgroup 2a (K=35-35.99 D), Subgroup 3a (K=36-36.99 D) and 
Subgroup 4a (K=37-37.99 D). Finally three, determine the existence of a relationship 
between CRLS type and postoperative BCVA loss. 
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METHODS 
Study Design 
A retrospective study was performed on eyes that had previously undergone 
refractive surgery Boston Eye Group/Boston Laser in Brookline, Massachusetts between 
December 2008 and November 2016. The refractive surgeries performed were LASIK or 
ASA (LASEK or PRK). Ablative excimer laser platforms used were the WaveLight EX500 
Excimer Laser (Alcon Laboratories Inc., Fort Worth, TX) and the VISX STAR S4 IR 
Excimer Laser System (Abbott Medical Optics Inc., Santa Ana, CA). LASIK flaps were 
created with the IntraLase iFS60 Laser (Abbott Medical Optics Inc., Santa Ana, CA).  
In order to qualify as a “Candidate” in this study the patient must have had a 
calculated postoperative keratometry less than 38 D, based on their horizontal and vertical 
meridian keratometries. Similarly, qualifying for the “Control” group was based on a 
calculated postoperative keratometry being greater than or equal to 38 diopters. These two 
groups were then matched based on the amount of tissue ablated during their surgical 
procedure. Patients were excluded if they were hyperopic, had previously had an ocular 
surgery procedure to correct vision (including retinal procedures), were an ASA patient 
with less than three months of follow-up, or if their treatment was not wavefront-guided or 
optimized. 
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Postoperative Keratometry Calculation 
The postoperative keratometry used to classify a patient into their Candidate or 
Control group and subgroup was based on the formulae proposed by Holladay et al.6 and 
Varssano et al.23 The preoperative spherical equivalent was achieved by multiplying the 
sum of the manifest preoperative sphere and half the manifest preoperative cylinder by 0.7. 
After refractive surgery it is expected to see a small amount of anterior corneal flattening, 
which is accounted for by taking 70% of the calculated spherical equivalence. This 
corrected spherical equivalence is then subtracted from the measured preoperative 
keratometry to give the approximate postoperative keratometry. 
Data and Statistical Analysis 
Prior to analysis or handling patient data was de-identified data and given an 
appropriate reference number. BCVA, as measured by the Snellen Visual Acuity Chart was 
converted to logMAR(BCVA) to allow for more detailed statistical analysis. Additionally, 
due to similarities in healing time, visual stability, and visual outcome, LASEK and PRK 
were combined into a single group called ASA (Advanced Surface Ablation), and 
considered as such for the purpose of statistical analyses. 
Patients belonging to the Candidate (<38D) group were furthered sectioned into 
subgroups by their calculate postoperative keratometry: 1a (K<35D), 2a (K=35-35.99D), 
3a (K=36-36.99D), 4a (K=37-37.99D). A similar type of stratification was applied to the 
Control (≥38) group, also giving four subgroups: 1b (K=38-38.99D), 2b (K=39-39.99D), 
3b (K=40-40.99D), and 4b (K≥41D). Once subgroups were assigned Candidate and 
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Control, patients were matched with their appropriate counter subgroup (e.g. 1a & 1b). 
Matching was performed by pooling the subgroups to be matched, randomizing the data 
order, and selecting those with equal or near equal microns of tissue ablated. 
Analyses were performed with IBM SPSS Statistics for Macintosh, Version 24. 
Graphs, figures, and charts were created in Microsoft Excel for Macintosh, Version 16.9. 
A number of analyses were performed including t-tests, Chi-Square tests, and ANOVAs. 
The appropriate test for each comparison was selected according to the variable types 
involved. For ANOVA post-hoc testing that involved samples of unequal size and variance, 
such as candidate or control subgroup comparisons, the Games-Howell (GH) test was used. 
This test was chosen due to its preference for more narrow confidence limits and higher 
statistical power than similar tests, such as Tamhane T220. The null hypothesis of all 
analysis tests assumed equal means or equal qualitative distribution. A p≤0.05 (a 
probability less than 5%) was considered statistically significant and p≤0.01 (probability 
less than 1%) was considered very statistically significant, leading to a rejection of the null 
hypothesis and indicating that the data differed significantly. 
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RESULTS 
A total of 111 eyes belonging to 92 patients were identified as candidates. A control 
population of 111 candidate eyes belonging to 89 individuals were selected by matching 
manifest refraction sphere and cylinder values with candidate patients.  
Preoperative Data 
Data collected from the overall candidate group showed a mean preoperative 
manifest sphere refraction of -5.3 D ± 1.76, mean manifest cylinder refraction of -1.07 D 
± 0.87, mean spherical equivalence of -5.85 D ± 1.81, mean tissue ablated 81.52 µm ± 1.81 
(Table 1), mean preoperative flat keratometry of 40.62 D ± 0.78, and mean steep 
keratometry of 41.80D ± 0.94 (Table 2). Data collected from the corresponding overall 
control group showed a mean preoperative manifest sphere refraction of -5.00 D ± 1.87, 
mean manifest cylinder refraction of -0.82 D ± 0.74, mean spherical equivalence of -5.41 
D ± 1.84, mean flat keratometry of 44.22D ±0.99, and mean steep keratometry of 45.43 D 
± 4.05. 
A two-sample t-test assuming unequal variance was used to compare candidate and 
control mean preoperative manifest sphere refraction (t(220) = -1.252, p=0.212), mean 
preoperative manifest cylinder refraction (t(220) = -2.418, p=0.016), mean preoperative 
spherical equivalence (t(220) = -1.794, p=0.074), and microns of tissue ablated (t(220) = -
0.052, p=0.958). Although there was a significantly different preoperative manifest 
cylinder refraction between candidates and controls (Table 3), t-tests between paired 
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subgroups (e.g. 1a & 1b) with regards to cylindrical refraction did not indicate rejection of 
the null hypothesis (Table 4).  
Table 3. Candidate and Control Comparison of Preoperative Manifest Sphere, Cylinder, Spherical 
Equivalence, and Amount of Tissue Ablated. 
 
The same type of t-test was performed on each subgroup pair with regards to 
preoperative manifest sphere, cylinder, spherical equivalence, and tissue ablated. Between 
1a & 1b, there were no significant differences between preoperative cylinder (t(26)=-1.368, 
p=.183) or tissue ablated (t(26)=0.069, p=0.946). However, there was a difference in 
preoperative manifest sphere (t(26)=0.403, p=0.003) and spherical equivalence (t(26)=-
4.404, p<0.001). Between 2a & 2b, there were no differences in preoperative sphere 
(t(40)=-0.355, p=0.724), spherical equivalence (t(40)=-1.737, p=.090), or tissue ablated 
(t(40)=-0.396, p=0.694). There was a significant difference in preoperative cylinder 
(t(40)=-2.358, p=.023). When comparing 3a & 3b, there were no significant differences in 
preoperative sphere (t(58)=0.043, p=0.966), cylinder (t(58)=-1.626, p=0.109), spherical 
equivalence (t(58)=-0.233, p=0.817), and tissue ablated (t(58)=0.013, p=0.989). Similarly, 
comparisons of 4a & 4b along preoperative sphere (t(90)=-1.195, p=0.236), cylinder (t(90) 
= 0.041, p=0.968), spherical equivalence (t(90)=-1.221, p=0.226), and tissue ablated 
Subgroup 
Matching 
Sphere Cylinder 
Spherical 
Equivalence 
Tissue Ablated 
Candidate 
& 
Control 
p=0.212 p=0.016 p=0.074 p=0.958 
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(t(90)=0.018, p=0.986) did not reject the null hypothesis. The comparative p-values are 
summarized in Table 4. 
Table 4. Candidate and Control Subgroup Comparison of Preoperative Manifest Sphere, Cylinder, 
Spherical Equivalence, and Amount of Tissue Ablated. 
 
Preoperative BCVA in logMAR was also compared between candidate and control 
groups. The means, standard deviation, and range are given in Table 5. In a two-tailed t-
test assuming unequal variance comparing the groups, there was no significant difference 
found (t(220)=-0.454, p=0.650). 
Table 5. Candidate and Control Preoperative Visual Acuity in logMAR. 
Subgroup 
Matching 
Sphere Cylinder 
Spherical 
Equivalence 
Tissue Ablated 
1a & 1b p=0.003 p=0.183 p<0.001 p=0.946 
2a & 2b p=0.724 p=0.023 p=0.090 p=0.694 
3a & 3b p=0.966 p=0.109 p=0.817 p=0.989 
4a & 4b p=0.236 p=0.968 p=0.226 p=0.986 
Group Mean Standard Deviation Range 
Candidate 
(N=111) 
0.000757 0.0212431 0.2218 
Control 
(N=111) 
0.002142 0.0241392 0.2218 
Total 
(N=222) 
0.001450 0.0226964 0.2218 
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Preoperative BCVA was also quantified for each of the candidate and control 
subgroups (Table 6 and 7). In a one-way Anova comparison of candidate subgroups 
resulted in a significant difference between the groups (F(3, 107)=3.001, p=0.034). When 
post-hoc testing was performed with the GH test, no significant differences resulted: 1a & 
2a (p=0.490), 1a & 3a (p=0.252), 1a & 4a (p=0.264), 2a & 3a (p=0.606), 2a & 4a (p=0.375), 
and 3a & 4a (p=1.000). A similar comparison was performed with the control subgroups 
but maintained the null-hypothesis (F(3, 107)=0.803, p=0.495).     
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Table 6. Candidate and Control Stratified Subgroups and Preoperative BCVA. 
 
  
Measure 
Candidates 
Subgroup 1a 
(K<35D) 
N=14 
Subgroup 2a 
(K=35-35.99D) 
N=21 
Subgroup 3a 
(K=36-36.99D) 
N=30 
Subgroup 4a 
(K=37-37.99D) 
N=46 
Total 
N=111 
Mean BCVA 
[logMAR 
(BCVA)] 
0.015271 0.002857 -0.002830 -0.002280 0.000757 
Standard 
Deviation 
0.0314254 0.0071714 0.0236058 0.0187147 0.0212431 
Range 
[logMAR 
(BCVA)] 
0.0969 0.0200 0.1449 0.1449 0.2218 
Manifest 
Sphere (D) 
-8.1250 -6.2381 -5.1167 -4.1467 -5.3063 
Manifest 
Cylinder (D) 
-1.3929 -1.8571 -0.7333 -0.8587 -1.0811 
Spherical 
Equivalence 
(D) 
-8.8236 -7.1688 -5.4853 -4.5789 -5.8492 
Actual 
Ablation (µm) 
107.21 98.33 79.40 67.41 81.52 
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Table 7. Candidate and Control Stratified Subgroups and Preoperative BCVA. 
 
  
Measure 
Control 
Subgroup 1b 
(K=38-38.99D) 
N=14 
Subgroup 2b 
(K=39-39.99D) 
N=21 
Subgroup 3b 
(K=40-40.99D) 
N=30 
Subgroup 4b 
(K≥41D) 
N=46 
Total 
N=111 
Mean BCVA 
[logMAR 
(BCVA)] 
0.008350 0.004614 -0.002830 0.002367 0.002142 
Standard 
Deviation 
0.0260377 0.0171267 0.0236058 0.0266022 0.0241392 
Range 
[logMAR 
(BCVA)] 
0.0969 0.0769 0.1449 0.2218 0.2218 
Manifest 
Sphere (D) 
-6.9821 -6.0833 -5.1333 -3.8152 -5.0000 
Manifest 
Cylinder (D) 
-.9821 -1.0357 -.5250 -0.8641 -0.8198 
Spherical 
Equivalence 
(D) 
-7.4746 -6.6019 -5.3970 -4.2477 -5.4107 
Actual 
Ablation (µm) 
107.00 99.52 79.33 67.35 81.68 
  
16 
Postoperative Data 
Data from the Candidate group showed a mean postoperative horizontal meridian 
keratometry of 36.53 D ± 1.15 and mean postoperative vertical meridian keratometry of 
37.71 D ± 1.16. Data collected from the corresponding control group showed a mean 
postoperative flat keratometry of 40.44 D ±1.2, and mean postoperative steep keratometry 
of 41.7 D ± 4.17 (Table 8). Candidate vs. control postoperative BCVA data according to a 
Snellen measurement is presented visually in Figure 1. 
Table 8. Candidate and Control Calculated Postoperative Horizontal Meridian (“Flat”) and Vertical 
Meridian (“Steep”) Keratometry. 
 
Group 
Measure 
Calculated Postop 
Flat K (D) 
Calculated Postop 
Steep K (D) 
Candidate 
(N=111) 
Mean 36.528437 37.712221 
Standard Deviation 1.1542562 1.1157949 
Range 4.7880 5.6750 
Control 
(N=111) 
Mean 40.435716 41.658144 
Standard Deviation 1.1970911 4.1744914 
Range 5.1520 44.5000 
Total 
(N=222) 
Mean 38.482077 39.685182 
Standard Deviation 2.2826276 3.6336809 
Range 10.0900 48.6625 
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Figure 1: Candidate vs. Control Postoperative Visual Acuity. Visual illustration of the postoperative 
BCVA of candidate patients with predicted postoperative keratometry values <38D vs. postoperative BCVA 
of control patients with predicted postoperative keratometry values ≥38D. X-axis represents visual acuity; 
Y-axis represents number of eyes. 
 
 
Postoperative BCVA was compared between candidate and control groups with a 
two-tailed t-test assuming unequal variance. Relevant logMAR(BCVA) values can be 
found in Table 9. The null hypothesis was not rejected (t(220)=1.754, p=0.081). The 
corrected visual acuity was further analyzed along the candidate and control subgroups. A 
single factor (“one-way”) ANOVA was conducted to compare the mean postoperative 
BCVA, in logMAR(BCVA), between the candidate subgroups 1a, 2a, 3a, and 4a (Table 
10). The analysis of variance showed no significant difference between the subgroup means 
(F(3, 107)=2.257, p=0.086). Another one-way ANOVA was used to compare the control 
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subgroups 1b, 2b, 3b, and 4b (Table 11). There was a significant difference between these 
subgroup means (F(3, 107)=3.137, p=0.028). Upon GH post-hoc testing there was no 
significant difference found between any pairs: 1b & 2b (p=0.431), 1b & 3b (p=0.101), 1b 
& 4b (p=0.587), 2b & 3b (p=0.535), 2b & 4b (p=0.932), and 3b & 4b (p=0.238). 
Table 9. Candidate and Control Postoperative Visual Acuity in logMAR. 
 
Loss of BCVA 
Of the overall candidate patient group a total of 3 out of 111 eyes (2.70%) lost 
BCVA, with 2 eyes losing 1 line of BCVA and 1 eye  losing 2+ lines of BCVA. Considering 
the control group, 1 out of 111 eyes (0.90%) lost 1 line of BCVA (Figure 2). 
  
Group Mean Standard Deviation Range 
Candidate 
(N=111) 
0.004766 0.0319170 0.3010 
Control 
(N=111) 
-0.002871 0.0329542 0.2418 
Total 
(N=222) 
0.000947 0.0325918 0.3010 
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Figure 2: Candidate vs. Control vs. Total Loss of BCVA. Left: Candidate (2 eyes or 1.8% of candidate 
eyes losing BCVA) and Control (1 eye or 0.90% of control eyes losing BCVA) Loss of 1 Line BCVA. 
Middle: Candidate (1 eye or 0.90% of candidate eyes losing BCVA) and Control (0 eyes or 0.00% of control 
eyes losing BCVA) Loss of 2+ Lines BCVA. Right: Candidate (3 eyes) and Control (1 eye) Loss of Total 
BCVA. X-axis represents loss of BCVA categories; Y-axis represents number of eyes.  
 
 
A more detailed look at the loss of postoperative BCVA is presented in Tables 12 
and 13. These tables contain the number of persons in each subgroup falling into each 
BCVA lost category, as well as the percentage of BCVA lost and maintained. 
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Table 12. Candidate Eyes That Lost BCVA by Subgroup and Relative Frequency of Total Subgroup 
Population. The number of eyes within each subgroup that lost either 1 line or 2+ lines of BCVA as a 
percentage of each subgroup population where n is the number of subjects.   
 
  
 
Measure 
Candidate Subgroups 
Subgroup 1a 
(K<35D) 
N=14 
Subgroup 2a 
(K=35-35.99D) 
N=21 
Subgroup 3a 
(K=36-36.99D) 
N=30 
Subgroup 4a 
(K=37-37.99D) 
N=46 
Total 
N=111 
Loss of 1 Line 
BCVA 
1 (7.14%) 0 (0%) 0 (0%) 1 (2.17%) 2 (1.80%) 
Loss of 2+ 
Lines BCVA 
0 (0%) 1 (4.76%) 0 (0%) 0 (0%) 1 (0.90%) 
Total Loss of 
BCVA 
1 (7.14%) 1 (4.76%) 0 (0%) 1 (2.17%) 3 (2.70%) 
BCVA Not 
Lost 
13 (92.86%) 20 (95.24%) 30 (100%) 45 (97.83%) 
108 
(97.30%) 
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Table 13. Control Eyes That Lost BCVA by Subgroup and Relative Frequency of Total Subgroup 
Population. The number of eyes within each subgroup that lost either 1 line or 2+ lines of BCVA as a 
percentage of each subgroup population where n is the number of subjects. 
 
To determine if more eyes within the candidate group lost BCVA in comparison to 
the control group, a Chi-Square test (χ2) was performed. The relationship between these 
groups was not significant (χ2 (1, N=222)=1.018, p=0.313). Two more Chi-Square tests 
were conducted to discover if BCVA changed among the candidate subgroups or control 
subgroups. Neither the control subgroups (χ2 (3, N=111)=2.270, p=0.290) nor the candidate 
subgroups (χ2 (3, N=111)=6.992, p=0.072) significantly differed from the other subgroups 
in their grouping category. 
In order to further investigate and understand the BCVA loss within each subgroup, 
preoperative and postoperative BCVAs were compared. For each subgroup, the 
Measure 
Control Subgroups 
Subgroup 1b 
(K=38-38.99D) 
N=14 
Subgroup 2b 
(K=39-39.99D) 
N=21 
Subgroup 3b 
(K=40-40.99D) 
N=30 
Subgroup 4b 
(K≥41) 
N=46 
Total 
N=111 
Loss of 1 Line 
BCVA 
1 (7.14%) 0 (0%) 0 (0%) 0 (0%) 1 (0.90%) 
Loss of 2+ 
Lines BCVA 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Total Loss of 
BCVA 
1 (7.14%) 0 (0%) 0 (0%) 0 (0%) 0 (0.90%) 
BCVA Not 
Lost 
13 (92.86%) 21 (100.00%) 30 (100.00%) 46 (100%) 110 (99.10%) 
  
22 
preoperative logMAR(BCVA) was compared with the postoperative logMAR(BCVA) via 
a one-way ANOVA for repeated measures. There was no significant change in any of the 
control (Table 14) or candidate (Table 15) subgroups. 
Table 14. Candidate Subgroup Mean Preoperative and Postoperative BCVA Comparison. 
 
Table 15. Control Subgroup Mean Preoperative and Postoperative BCVA Comparison. 
 
Surgery Type 
There were 111 candidate eyes. 104 (93.69%) underwent LASIK and 7 (6.31%) 
underwent ASA surgery. In comparison, of the 111 control eyes 83 (74.77%) underwent 
LASIK and 28 (25.23%) underwent ASA. A Chi-Square test for independence was 
performed to determine if one the groups (candidate or control) had a greater prevalence 
of ASA or LASIK in comparison to the along. This was found to be significant, with the 
Candidate Subgroup Pre- and Postoperative BCVA Comparison 
Subgroup 
Subgroup 1a 
(K<35D) 
N=14 
Subgroup 2a 
(K=35-35.99D) 
N=21 
Subgroup 3a 
(K=36-36.99D) 
N=30 
Subgroup 4a 
(K=37-37.99D) 
N=46 
Total 
N=111 
p-value 0.367 0.297 0.576 0.669 0.157 
Candidate Subgroup Pre- and Postoperative BCVA Comparison 
Subgroup 
Subgroup 1b 
(K=38-38.99D) 
N=14 
Subgroup 2b 
(K=39-39.99D) 
N=21 
Subgroup 3b 
(K=40-40.99D) 
N=30 
Subgroup 4b 
(K≥41) 
N=46 
Total 
N=111 
p-value 0.458 0.227 0.071 0.703 0.100 
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control group containing more ASA eyes (χ2 (1, N=222)=14.958, p<0.001). Average 
follow-up time was 122 days for LASIK eyes and 229 days for ASA patients. 
Overall, of both the candidate and control groups, 187 eyes underwent LASIK of 
which 3 eyes lost BCVA (1.60%). Similarly, 35 eyes underwent ASA and 1 eye lost BCVA 
(2.86%). To determine if these rates corresponded, a Chi-Square test was conducted to 
analyze whether a loss of BCVA was dependent on surgery type. The relationship between 
these groups was not significant, (χ2 (1, N=222)=0.069, p=0.793). Additional Chi-Squares 
were performed on both the candidate and control subgroups. The candidate subgroups had 
no significant difference in the comparison of treatment type and loss of BCVA (χ2 (1, 
N=111)=0.208, p=0.649). Similarly, the control subgroups also showed no differences 
along those criteria (χ2 (1, N=111)=2.991, p=0.084). 
Of the 3 candidate eyes that lost 1 or more lines of BCVA, all had undergone 
LASIK and had a mean follow-up time of 101 days. The 1 control eye that lost BCVA had 
been treated with ASA and had a mean follow-up period of 341. Also of note, is that none 
of the 4 eyes that lost BCVA had experienced intraoperative complications. 
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DISCUSSION 
This investigation was undergone with the principle goal of discovering if patients 
with a flat calculated postoperative keratometry (<38 D) were at an increased risk of losing 
BCVA following CRLS. It also endeavored to determine if the degree of corneal flattening 
following surgery, as designated by calculated keratometry values (K<35 D, K=35-35.99 
D, K=36-36.99 D, and K=37-37.99 D), was related to BCVA loss. Finally, we attempted 
to determine if type of refractive surgery had any role in postoperative VA, corneal 
flattening, or BCVA loss.  
Candidate-Control Matching 
When matching candidates and controls among their respective subgroups (e.g. 1a 
& 1b) we chose to focus on the amount of tissue actually ablated during surgery as opposed 
to matching based on preoperative manifest prescriptions. Multiple rationales led to this 
decision. Principally, we wanted to provide as accurate a match as possible when 
comparing postoperative keratometry. Those with flat K’s tend to have higher myopic 
manifest SE than those with normal keratometry and we did not want this discrepancy to 
factor in to our comparisons. Furthermore it is extremely unlikely that the operating 
surgeon would chose to ablate more than 130µm of tissue, no matter the prescription or 
pupil size, due to the risk of corneal ectasia. For similar reasons it is extremely rare for a 
surgeon to perform refractive surgery on patients with keratoconus, a condition 
characterized by a unstable corneal structure. Corneal ectasia can result from too great an 
alteration of the cornea and can permanently impair vision. Vision is compromised when 
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the cornea’s structure is comprised and as a result is too weak to properly refract light.17,18 
It follows that matching the amount of tissue removed between pairs should give a more 
robust pairing than manifest prescription. 
There were significant differences found between candidate and control cylinder 
manifests (p=0.016) and subgroup 2a & 2b cylinder (p=0.023). There were also significant 
differences in subgroup 1a & 1b sphere (p=0.003) and spherical equivalence (p<0.001). As 
previously mentioned those with very large prescriptions were not fully treated if that 
would lead to an increase in risk of corneal ectasia. There were no statistically significant 
differences in the amount of tissue ablated between candidate and control or between 
candidate and control subgroups.  
There was a significantly greater representation of those undergoing ASA as 
opposed to LASIK in the control group (p<0.001). However, we do not feel this was a 
confounding factor or influenced results due to the lack of differences in postoperative 
visual outcome. Whether the patient had LASIK or ASA, there was no significant 
difference in either BCVA or BCVA loss. Therefore, we do not feel that these differences 
impacted our patient matching or results. 
Overall Loss of BCVA 
3 candidate eyes (2.70%) lost 1 or more lines of BCVA. There was only a single 
control eye (0.90%) that lost BCVA. Upon further analysis, there was no statistically 
significant difference (p=0.313) found between candidate (K<38 D) and control (K≥38 D) 
eyes. These results were similar to those by Varssano et al.23, though they chose to use 
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different cutoff keratometry values to determine their candidate (K<35 D) and control 
(K≥35 D) groups. 
Subgroup Loss of BCVA 
No significant differences in BCVA loss were found between the candidate or 
control subgroups. This is supportive of statements by Varssano et al.23 Their candidate 
group had no significant difference in BCVA loss compared to the control group. A study 
by Mostafa11 stratified patients by degree of myopia (-6 to -7.9 D, -8 to -9.9 D, and -10 to 
-12 D) and  measured their postoperative corrected distance visual acuity (CDVA) in eyes 
with postoperative keratometry 35 D. The study found that flat corneas and higher degrees 
of myopia led to worse CDVA outcomes postoperative. However, it is difficult to this study 
to the current investigation due to our lack of myopic stratification. 
Multiple studies in the current literature have indicated that patients with a higher 
degree of myopia (especially -8 to -14 D) are at an increased risk of losing BCVA if they 
undergo CRLS, as summarized by a recent Cochrane review.1 As mentioned previously, 
higher degrees of myopia require a larger percentage of corneal tissue to be laser altered 
and may greatly increase the risk of corneal ectasia. 
Surgery Type 
Our study had a larger percentage of candidate LASIK patients (93.69%) than 
controls (74.77%), which had a higher percentage of ASA patients (25.23%) than the 
candidate group (6.31%). This difference was significant (p<0.001). However, there was 
no distinction made between the amount of BCVA lost and procedure type (p=0.793) 
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indicating that procedure type had no major role in determine BCVA outcome. This is 
further supported by a minimum required amount of follow-up time for LASIK and ASA 
patients, with ASA requiring longer to achieve BCVA stability. The average follow-up for 
LASIK eyes was 122 days and for ASA eyes was 229 days. 
To our knowledge there is no other study in the current literature that considers the 
effect of procedure type (LASIK or ASA) on postoperative VA in flat corneas. Varssano 
et al.23 investigated patients undergoing PRK and Mostafa11 confined his research to 
LASIK patients. 
Current Limitations and Future Studies 
The most prominent limitation in this investigation is the use of mathematically 
predicted postoperative keratometry. Though this method is commonly used to help 
evaluate CRLS candidacy,23 its validity as a predictive tool has not been exhaustively 
tested. Further large-scale studies comparing predicted and measure postoperative 
keratometry are warranted.  
Our study is also hampered by a lack of measured postoperative keratometry. These 
values and their correlation to postoperative VA would further define our current findings 
and increase their validity. We recommend similar, large-scale, controlled studies to 
effectively evaluate this relationship. 
Though we consider a fairly significant sample size (222 eyes), it is possible that 
sampling error may have skewed our results. Future investigations could possibly avoid 
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this by increasing sample size and/or including multiple surgery sites, potentially in 
significantly different geographic areas. 
In conclusion, our evidence suggests there is no relationship between loss of BCVA 
and a postoperative corneal keratometry of less than 38 D. 
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APPENDIX 
Table 1. Candidate and Control Preoperative Manifest Sphere, Cylinder, Spherical Equivalence, and 
Amount of Tissue Ablated. 
 
  
Group Measure Sphere (D) Cylinder (D) 
Spherical 
Equivalence 
(D) 
Tissue Ablated 
(µm) 
Candidate 
(N=111) 
Mean -5.3063 -1.0811 -5.8492 81.52 
Standard 
Deviation 
1.77280 .86875 1.80524 20.806 
Range 9.00 4.75 8.87 88 
Control 
(N=111) 
Mean -5.0000 -.8198 -5.4107 81.68 
Standard 
Deviation 
1.87204 .73560 1.83624 22.742 
Range 8.25 3.50 7.87 105 
Total 
(N=222) 
Mean -5.1532 -.9505 -5.6300 81.60 
Standard 
Deviation 
1.82543 .81371 1.82993 21.746 
Range 9.00 4.75 9.12 105 
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Table 2. Candidate and Control Preoperative Horizontal Meridian (“Flat”) and Vertical Meridian 
(“Steep”) Keratometry. 
 
  
Group Measure Flat K (D) Steep K (D) 
Candidate 
(N=111) 
Mean 40.62099 41.80468 
Standard Deviation 0.781309 0.940851 
Range 3.750 5.250 
Control 
(N=111) 
Mean 44.22243 45.44477 
Standard Deviation 0.992038 4.046393 
Range 5.000 44.000 
Total 
(N=222) 
Mean 42.42171 43.62473 
Standard Deviation 2.012697 3.452210 
Range 8.250 46.500 
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Table 10. Candidate Stratified Subgroups and Postoperative BCVA. Total number of persons in each 
stratified candidate group and associated postoperative BCVA. 
 
  
 
 
Measure 
Candidate: Postoperative BCVA 
Subgroup 1a 
(K<35D) 
N=14 
Subgroup 2a 
(K=35-35.99D) 
N=21 
Subgroup 3a 
(K=36-36.99D) 
N=30 
Subgroup 4a 
(K=37-37.99D) 
N=46 
Total 
N=111 
Mean BCVA 
[logMAR 
(BCVA)] 
0.020764 0.012195 0.000503 -0.000715 0.005459 
Standard 
Deviation 
0.0382870 0.0383979 0.0221254 0.0307846 0.0326391 
Range 
[logMAR 
(BCVA)] 
0.0969 0.1761 0.1249 0.2418 0.3010 
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Table 11. Control Stratified Subgroups and Postoperative BCVA. Total number of persons in each 
stratified control group and associated postoperative BCVA. 
 
 
  
 
 
Measure 
Control Postoperative BCVA 
Subgroup 1b 
(K=38-38.99D) 
N=14 
Subgroup 2b 
(K=39-39.99D) 
N=21 
Subgroup 3b 
(K=40-40.99D) 
N=30 
Subgroup 4b 
(K≥41D) 
N=46 
Total 
N=111 
Mean BCVA 
[logMAR 
(BCVA)] 
0.013843 -0.003090 -0.015987 0.000696 -0.002871 
Standard 
Deviation 
0.0360518 0.0240868 0.0436020 0.0241142 0.0329542 
Range 
[logMAR 
(BCVA)] 
0.1169 0.1249 0.1449 0.2218 0.2418 
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